Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 1c, Lowers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Zimmer Biomet (ZBH) PT Lowered to $175 at Jefferies
November 5, 2021 8:17 AM EDTJefferies analyst Raj Denhoy lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $200.00) while maintaining a Buy rating.
The analyst commented, "Key 2Q post call details: 1) Delta/Staffing impacts are expected to persist into 4Q at heightened level, 2) China VBP... More
Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities
November 4, 2021 6:09 PM EDTTruist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.
The analyst commented, "The third quarter was another noisy event for Zimmer Biomet headlined by COVID, staffing, and VBP headwinds that impacted... More
Zimmer Biomet (ZBH) PT Lowered to $175 at Needham & Company
November 4, 2021 1:45 PM EDTNeedham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $187.00) while maintaining a Strong Buy rating.
The analyst commented, "ZBH's 3Q21 revenue missed while EPS beat consensus. Growth slowed due to procedure disruption and a tougher comp... More
